Curative Biotechnology Inc (CUBT) — Cash Flow-to-Debt Ratio
Curative Biotechnology Inc (CUBT) has a Cash Flow-to-Debt Ratio of -0.02x as of March 2026, meaning its operating cash flow of $-193.12K could theoretically repay 0% of its total liabilities ($8.37 Million) in one year. Check total reinvestment intensity of Curative Biotechnology Inc to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Curative Biotechnology Inc Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Curative Biotechnology Inc across 13 annual periods. Also explore how large is Curative Biotechnology Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Curative Biotechnology Inc (2013–2025)
Year-by-year debt coverage analysis for Curative Biotechnology Inc. For market capitalisation and broader financial context, see Curative Biotechnology Inc (CUBT) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.11x | $-868.87K | $8.20 Million | ▲ +26.7% |
| 2024 | -0.14x | $-1.02 Million | $7.08 Million | ▼ -70.7% |
| 2023 | -0.08x | $-486.58K | $5.75 Million | ▼ -24.7% |
| 2022 | -0.07x | $-1.54 Million | $22.62 Million | ▲ +20.5% |
| 2021 | -0.09x | $-1.60 Million | $18.77 Million | ▼ -205.4% |
| 2020 | -0.03x | $-190.09K | $6.80 Million | ▼ -7305.3% |
| 2019 | 0.00x | $-150.00 | $397.10K | ▼ -84.9% |
| 2018 | 0.00x | $-150.00 | $734.36K | ▲ +2.2% |
| 2017 | 0.00x | $-150.00 | $718.33K | ▲ +97.5% |
| 2016 | -0.01x | $-5.89K | $702.29K | ▼ -394.8% |
| 2015 | 0.00x | $1.96K | $687.16K | ▲ +113.0% |
| 2014 | -0.02x | $-20.99K | $960.99K | ▲ +42.9% |
| 2013 | -0.04x | $-35.68K | $932.66K | — |